JWJian Wang

Jian Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jian Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Baoyou Zhang

    Department of Cardiac and Thoracic Vascular Surgery, The First People’s Hospital of Jiashan County

    3 shared publications
  • Fan Gao

    Department of Simulation Science and Technology, Shaanxi Xinmai Medical Technology Co., Ltd

    2 shared publications
  • Zhixuan Bai

    Department of Cardiovascular Surgery, The Second Affiliated Hospital of Zhejiang University's Medical School, Hangzhou, Zhejiang, China

    2 shared publications
  • Bing Chen

    Department of Vascular Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China; State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China

    1 shared publication
  • Fengming Luan

    Department of General Surgery, The Second Affiliated Hospital of Zhejiang, University’s Medical School, Hangzhou, China

    1 shared publication
  • Ling Jin

    Department of Cardiac and Thoracic Vascular Surgery, The First People’s Hospital of Jiashan County, The Second Affiliated Hospital of Zhejiang University, Jiaxing, China

    1 shared publication

Latest Publications

  • Open Access

    A patient-specific CTA-CFD framework deciphers hemodynamic heterogeneity after fenestrated TEVAR: a pilot study

    by Baoyou Zhang, Fan Gao, Jian Wang, Wenpu Zhang

    Background and Objectives: Despite the widespread use of fenestrated thoracic endovascular aortic repair (TEVAR), clinical outcomes exhibit considerable heterogeneity whose underlying hemodynamic mechanisms remain poorly understood. This study aimed to establish a patient-specific computational framework integrating postoperative computed tomography angiography (CTA) and computational fluid dynamics (CFD) to quantitatively evaluate morpho-hemodynamic alterations after fenestrated TEVAR. Methods: Six aortic dissection patients undergoing TEVAR with left subclavian artery (LSA) fenestration (three in situ , three in vitro ) were included. Patient-specific 3D aortic geometries were reconstructed from postoperative CTA. High-fidelity CFD simulations were performed to analyze flow distribution, velocity, time-averaged wall shear stress (TAWSS), and oscillatory shear index (OSI). Results: Computational analysis revealed that the brachiocephalic trunk was the least affected vessel following TEVAR (median AR BT 0.80, IQR 0.74–0.89). Notable abnormalities included one case of severe LSA stenosis (AR LSA = 5.25, V LSA, systole = 1.15 m/s), and one instance of mild stent-induced proximal LCCA compromise (AR LCCA = 1.27, V LCCA, systole = 1.06 m/s), both demonstrating TAWSS elevation at affected segments. Additionally, one patient exhibited inadequate endovascular recovery in the descending aorta, which received only 42.83% of the total cardiac output. The remaining patients showed no significant hemodynamic abnormalities. Conclusion: This pilot study establishes a patient-specific computational framework that integrates CTA with CFD to decipher post-intervention morpho-hemodynamic alterations. By quantitatively linking stent-induced geometric changes to adverse hemodynamic phenotypes, the demonstrated methodology explores a mechanistic approach for understanding post-surgical outcome disparities, thereby establishing a computational tool for postoperative evaluation. The clinical utility and predictive value of this tool, however, await validation in larger, prospective cohorts.

  • Open Access

    Quantitative evaluation of computational fluid dynamics application development in the cardiovascular field through literature retrieval and bibliometric analysis

    by Fan Gao, Tingting Yang, Jian Wang, Baoyou Zhang

    The application of computational fluid dynamics (CFD) in the cardiovascular field has been increasingly observed to analyze hemodynamic conditions within i

  • Systematic review and meta-analysis of current evidences in endograft therapy vs. medical treatment for Spontaneous Isolated Superior Mesenteric Artery Dissection

    by Baoyou Zhang, Yuexin Shen, Ling Jin, Jian Wang

    Objective Endovascular stent therapy (EST) for spontaneous isolated superior mesenteric artery dissection (SISMAD) is gaining popularity, yet the treatment strategy - BMT or EST - remains debatable. Methods A meta-analysis examined all randomized trials and observational studies exploring the relative merits and potential risks of EST vs. BMT in treating SISMAD patients. Key outcomes included early and long-term adverse effects, with odds ratios (ORs) and 95% confidence intervals (CI) calculated. A random- or fixed-effects model was selected according to a 50% heterogeneity threshold. Results 9 observational studies involving a total of 672 SISMAD patients (303 EST), met our selection criteria. We discovered no noteworthy distinctions between the EST group and the BMT group in terms of early symptoms’ alleviation, reinterventions, or all-cause mortality. However, patients receiving EST management will be hospitalized longer than those receiving BMT (EST: 13.2 ± 5.1 months vs. BMT: 7.0 ± 2.2 months, P < 0.01). In the long run, EST was found to significantly contribute to a higher rate of complete remodeling (OR: 4.53, CI: 3.01 ~ 6.81, P < 0.01; heterogeneity, I2 = 50%) and a lower incidence of aneurysm formation (OR: 0.19, CI: 0.06 ~ 0.6, P < 0.01; heterogeneity, I2 = 0%) than BMT. However, there are no significant differences between ESTand BMTin terms of all-cause mortality, recurrent syndrome, reintervention, and SMA stenosis or occlusion. Conclusion EST can effectively prevent the formation of aneurysmal dissection and improve SISMAD remodeling. Both EST and BMT are similar in reducing long-term mortality, recurrent symptoms, severe SMA stenosis or occlusion, and the need for reintervention in patients with SISMAD.


  • Systematic review and meta-analysis of current evidence in endograft therapy for spontaneous isolated superior mesenteric artery dissection

    by Jian Wang, Fengming Luan, Zhixuan Bai, Zhengjie Liu

    The role of endovascular stent therapy (EST) in the treatment of spontaneous isolated superior mesenteric artery dissection (SISMAD) has gained momentum in recent years but remains controversial. We gathered research examining the advantages and disadvantages of EST for SISMAD patients. Primary outcomes involved both immediate and long-term results. Random or fixed effect models were used for effect size (ES) calculation with 95% confidence interval (CI) based on 50% heterogeneity threshold. Our analysis incorporated data from 21 studies including 611 SISMAD cases treated by EST. Our findings show a complication rate of approximately 1% following EST (95%CI 0.01–0.02, I2 = 0%, P = 0.97), with a bare minimum mortality rate of < 1% (95%CI 0.00–0.01, I2 = 0%, P > 0.05) and a reintervention rate of < 1% (95%CI 0.00–0.01, I2 = 0%, P = 0.89). We also found technique success and symptom resolution approaching 94% and 99%, respectively, in the immediate postoperative phase. In the long run, we observed a recurrence of symptoms at 3% (95%CI 0.00–0.06, I2 = 58.6%, P < 0.01), creation of new dissections at 1% (95%CI 0.00–0.02, I2 = 0%, P = 0.73), aneurysm progression at 2% (95%CI 0.00–0.03, I2 = 42.7%, P = 0.12), reintervention due to complications at 3% (95%CI 0.00–0.05, I2 = 0%, P = 0.43) and stenotic stents at 12% (95%CI 0.04–0.23, I2 = 77.5%, P < 0.01). Nevertheless, high levels of stent patency 98% (95% CI 0.97–1.00, I2 = 0%, P = 0.51) and complete remodeling 88% (95% CI 0.82–0.94, I2 = 65.5%, P < 0.05) were observed postoperatively. Overall, EST presents minimal complications and promising long-term outcomes for SISMAD, although the prevalence of stent stenosis requires further attention.